About this file

This document is a combined synopsis/solicitation for a non-competitive, brand-name acquisition of barcoded and unbarcoded 384-well and 1536-well microplates for the National Center for Advancing Translational Sciences (NCATS) Antiviral Program for Pandemics (APP). The National Institute on Drug Abuse (NIDA) intends to award a purchase order to Greiner Bio-One North America, Inc. without full and open competition.

The requirement includes 75 cases of 1536-well black microplates, 40 cases of 1536-well white microplates, 30 cases of 1536-well white TC-treated microplates, 10 cases of 1536-well white/clear microplates with custom barcodes, and various quantities of 384-well microplates. The microplates must be compatible with NCATS' robotic screening systems. Responses to the solicitation are due by 11:00 am ET on April 26, 2024. The anticipated delivery date is 30 days after award. The purchase order will be awarded to the responsible offeror whose quote is most advantageous to the Government, considering technical capability and price.

View the file

On GovTribe

Work with this file

  • Download the original file
  • Contacts named in this file
  • Similar government files
  • Ask GovTribe AI about this file

Text version

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

PURCHASE DESCRIPTION

Statement of Need and Purpose: The purpose of this procurement is the acquisition of barcoded and unbarcoded 384-well and 1536-well microplates for Antiviral Program for

Pandemics (APP) and Automation for the 2024 screening season.

Background Information and Objective: The National Center for Advancing Translational

Sciences (NCATS) is a part of the National Institutes of Health (NIH), which mission it is to catalyze the generation of innovative methods and technologies that will enhance the development, testing and implementation of diagnostics and therapeutics across a wide range of human diseases and conditions. The Antiviral Program for Pandemics (APP) aims to develop safe and effective antivirals to combat SARS-CoV-2. APP will accelerate the development of a portfolio of promising antivirals that can quickly pivot to combat future pandemics. Having safe and effective oral antiviral candidates ready for deployment in later-stage clinical trials against a newly emergent virus would save lives, reduce serious illness and prevent overwhelming surges in hospitalizations during a viral outbreak or pandemic.

The APP and other biology groups as needed are in full swing ramping up into their screening season on the robotic systems and as a result will need of various 384-well and 1536-well microplates in order to perform their scheduled assay screens and combination matrix studies for a vast quantity of projects. The particular plates are available through Greiner-Bio who has provided us with a customized quote specifically for NCATS.

Generic Name of Product: 1536-well and 384-well Microplates for Automated Combination

Matrix Screening

Purchase Description:

• 789176-F 1536 well assay plate, black, MB

• 789175-F 1536 well assay plate, white, MB

• 789173-F 1536 well assay plate, white, TC, 60 cases total

• 789093-F GNF Divisions 1536W, PS, Sterile, TC Treated, WHT/CLR, w/ 2 Custom Barcodes, 10 cases

• 789092-F GNF Divisions 1536W, PS, Sterile, TC Treated, BLK/CLR, w/ 2 Custom Barcodes, 75 cases total

• 781075 384 well assay plate, white, lumitrac

• 781076 384 well assay plate, black, fluotrac

Salient characteristics

Dual barcode

TC treated

Version 11-30-2016-1 FAR Part 11—Describing Agency Needs

Quantity:

• 75 cases of 1536 well assay plate, black, MB

• 40 cases of 1536 well assay plate, white, MB

• 30 cases of 1536 well assay plate, white, TC

• 10 cases of GNF Divisions 1536W, PS, Sterile, TC Treated, WHT/CLR, w/ 2 Custom Barcodes

• 1 case of MICROPLATE, 384 WELL, PS, F-BOTTOM, BLACK, STREPTAVIDIN-COATED, 5

PCS./BAG

• 4 cases of CELL CULTURE MICROPLATE, 384 WELL, PS,µCLEAR®, BLACK, POLY-D-

LYSINE, CELLCOAT®,lID, 5 PCS./BAG

• 4 cases of CELL CULTURE MICROPLATE, 384 WELL, PS, µCLEAR®, WHITE, POLY-D-

LYSINE, CELLCOAT®,LID, 5 PCS./BAG"

• 11 cases of 384 well assay plate, white, lumitrac

• 9 cases of 384 well assay plate, black, fluotrac

Delivery Date: 30 days ARO

Period of Performance: One-Time Delivery

Option(s): N/A

File details come from the government source that posted it. Updated .